{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:00:37Z","timestamp":1780434037582,"version":"3.54.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:00:00Z","timestamp":1584748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T00:00:00Z","timestamp":1584748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00018-020-03495-x","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T07:02:33Z","timestamp":1584774153000},"page":"3369-3381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Controversies in TWEAK-Fn14 signaling in skeletal muscle atrophy and regeneration"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3555-6856","authenticated-orcid":false,"given":"Amy L.","family":"Pascoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4289-3516","authenticated-orcid":false,"given":"Amelia J.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3697-589X","authenticated-orcid":false,"given":"Robyn M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,21]]},"reference":[{"issue":"1","key":"3495_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1152\/jappl.2000.89.1.81","volume":"89","author":"I Janssen","year":"2000","unstructured":"Janssen I, Heymsfield SB, Wang ZM, Ross R (2000) Skeletal muscle mass and distribution in 468 men and women aged 18\u201388 yr. J Appl Physiol 89(1):81\u201388","journal-title":"J Appl Physiol"},{"issue":"4","key":"3495_CR2","doi-asserted-by":"publisher","first-page":"C834","DOI":"10.1152\/ajpcell.00579.2003","volume":"287","author":"RW Jackman","year":"2004","unstructured":"Jackman RW, Kandarian SC (2004) The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287(4):C834\u2013C843. https:\/\/doi.org\/10.1152\/ajpcell.00579.2003","journal-title":"Am J Physiol Cell Physiol"},{"key":"3495_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fimmu.2014.00034","volume":"5","author":"EK Enwere","year":"2014","unstructured":"Enwere EK, Lacasse EC, Adam NJ, Korneluk RG (2014) Role of the TWEAK-Fn14-cIAP1-NF-kappaB signaling axis in the regulation of myogenesis and muscle homeostasis. Front Immunol 5:34. https:\/\/doi.org\/10.3389\/fimmu.2014.00034","journal-title":"Front Immunol"},{"issue":"19","key":"3495_CR4","doi-asserted-by":"publisher","first-page":"12976","DOI":"10.1074\/jbc.M114.563478","volume":"289","author":"S Gurunathan","year":"2014","unstructured":"Gurunathan S, Winkles JA, Ghosh S, Hayden MS (2014) Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation. J Biol Chem 289(19):12976\u201312988. https:\/\/doi.org\/10.1074\/jbc.M114.563478","journal-title":"J Biol Chem"},{"issue":"51","key":"3495_CR5","doi-asserted-by":"publisher","first-page":"32401","DOI":"10.1074\/jbc.272.51.32401","volume":"272","author":"Y Chicheportiche","year":"1997","unstructured":"Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272(51):32401\u201332410","journal-title":"J Biol Chem"},{"issue":"5","key":"3495_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrd2488","volume":"7","author":"JA Winkles","year":"2008","unstructured":"Winkles JA (2008) The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7(5):411\u2013425. https:\/\/doi.org\/10.1038\/nrd2488","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3495_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2249.2011.04442.x","volume":"166","author":"T Chen","year":"2011","unstructured":"Chen T, Guo ZP, Li MM, Li JY, Jiao XY, Zhang YH, Liu HJ (2011) Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura. Clin Exp Immunol 166(1):64\u201371. https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04442.x","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"3495_CR8","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1084\/jem.192.9.1373","volume":"192","author":"M Nakayama","year":"2000","unstructured":"Nakayama M, Kayagaki N, Yamaguchi N, Okumura K, Yagita H (2000) Involvement of tweak in interferon \u03b3\u2013stimulated monocyte cytotoxicity. J Exp Med 192(9):1373\u20131380","journal-title":"J Exp Med"},{"issue":"24","key":"3495_CR9","doi-asserted-by":"publisher","first-page":"5826","DOI":"10.1038\/sj.emboj.7601441","volume":"25","author":"M Girgenrath","year":"2006","unstructured":"Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SAN, Winkles JA, Michaelson JS, Allaire N, Schneider P, Scott ML, Hsu YM, Yagita H, Flavell RA, Miller JB, Burkly LC, Zheng TS (2006) TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J 25(24):5826\u20135839. https:\/\/doi.org\/10.1038\/sj.emboj.7601441","journal-title":"EMBO J"},{"issue":"1","key":"3495_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2007.09.007","volume":"40","author":"LC Burkly","year":"2007","unstructured":"Burkly LC, Michaelson JS, Hahm K, Jakubowski A, Zheng TS (2007) TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK\/Fn14 pathway in health and disease. Cytokine 40(1):1\u201316. https:\/\/doi.org\/10.1016\/j.cyto.2007.09.007","journal-title":"Cytokine"},{"issue":"16","key":"3495_CR11","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1038\/sj.onc.1208208","volume":"24","author":"JS Michaelson","year":"2005","unstructured":"Michaelson JS, Cho S, Browning B, Zheng TS, Lincecum JM, Wang MZ, Hsu Y-M, Burkly LC (2005) Tweak induces mammary epithelial branching morphogenesis. Oncogene 24(16):2613\u20132624. https:\/\/doi.org\/10.1038\/sj.onc.1208208","journal-title":"Oncogene"},{"issue":"4","key":"3495_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/01.ATV.0000258972.10109.ff","volume":"27","author":"LM Blanco-Colio","year":"2007","unstructured":"Blanco-Colio LM, Martin-Ventura JL, Munoz-Garcia B, Orbe J, Paramo JA, Michel JB, Ortiz A, Meilhac O, Egido J (2007) Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 27(4):916\u2013922. https:\/\/doi.org\/10.1161\/01.ATV.0000258972.10109.ff","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"3495_CR13","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2007.10.022","volume":"199","author":"S Kralisch","year":"2008","unstructured":"Kralisch S, Ziegelmeier M, Bachmann A, Seeger J, Lossner U, Bluher M, Stumvoll M, Fasshauer M (2008) Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease. Atherosclerosis 199(2):440\u2013444. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.10.022","journal-title":"Atherosclerosis"},{"issue":"8","key":"3495_CR14","doi-asserted-by":"publisher","first-page":"E1323","DOI":"10.1210\/jc.2012-4177","volume":"98","author":"E Maym\u00f3-Masip","year":"2013","unstructured":"Maym\u00f3-Masip E, Vendrell J, Garrifo-Sanchez L, Fern\u00e1ndez-Veledo S, Chac\u00f3n MR, V\u00e1zquez-Carballo A, Garcia Espa\u00f1a A, Tinahones FJ, Garc\u00eda-Fuentes E, Rodriguez MdM (2013) The rise of soluble TWEAK levels in severely obese subjects after bariatric surgery may affect adipocyte-cytokine production induced by TNF\u03b1. J Clin Endocrinol Metab 98(8):E1323\u2013E1333. https:\/\/doi.org\/10.1210\/jc.2012-4177","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"3495_CR15","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1172\/jci23486","volume":"115","author":"A Jakubowski","year":"2005","unstructured":"Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, Browning B, Michaelson JS, Baetscher M, Wang B, Bissell DM, Burkly LC (2005) TWEAK induces liver progenitor cell proliferation. J Clin Invest 115(9):2330\u20132340. https:\/\/doi.org\/10.1172\/jci23486","journal-title":"J Clin Invest"},{"key":"3495_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26525","author":"C Zhu","year":"2017","unstructured":"Zhu C, Zhang L, Liu Z, Li C, Bai Y (2017) TWEAK\/Fn14 interaction induces proliferation and migration in human airway smooth muscle cells via activating the NF-kappaB pathway. J Cell Biochem. https:\/\/doi.org\/10.1002\/jcb.26525","journal-title":"J Cell Biochem"},{"key":"3495_CR17","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3389\/fphar.2018.00660","volume":"9","author":"J Liu","year":"2018","unstructured":"Liu J, Peng L, Liu Y, Wu K, Wang S, Wang X, Liu Q, Xia Y, Zeng W (2018) Topical TWEAK accelerates healing of experimental burn wounds in mice. Front Pharmacol 9:660. https:\/\/doi.org\/10.3389\/fphar.2018.00660","journal-title":"Front Pharmacol"},{"issue":"34","key":"3495_CR18","doi-asserted-by":"publisher","first-page":"32317","DOI":"10.1074\/jbc.M302518200","volume":"278","author":"TC Polek","year":"2003","unstructured":"Polek TC, Talpaz M, Darnay BG, Spivak-Kroizman T (2003) TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14\/TweakR. Evidence for a second TWEAK receptor. J Biol Chem 278(34):32317\u201332323. https:\/\/doi.org\/10.1074\/jbc.M302518200","journal-title":"J Biol Chem"},{"key":"3495_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3389\/fphar.2019.00735","volume":"10","author":"G Xiao","year":"2019","unstructured":"Xiao G, Lyu M, Wang Y, He S, Liu X, Ni J, Li L, Fan G, Han J, Gao X, Wang X, Zhu Y (2019) Ginkgo flavonol glycosides or ginkgolides tend to differentially protect myocardial or cerebral ischemia-reperfusion injury via regulation of TWEAK-Fn14 signaling in heart and brain. Front Pharmacol 10:735. https:\/\/doi.org\/10.3389\/fphar.2019.00735","journal-title":"Front Pharmacol"},{"issue":"8","key":"3495_CR20","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1096\/fj.06-7537com","volume":"21","author":"C Dogra","year":"2007","unstructured":"Dogra C, Changotra H, Wedhas N, Qin X, Wergedal JE, Kumar A (2007) TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J 21(8):1857\u20131869. https:\/\/doi.org\/10.1096\/fj.06-7537com","journal-title":"FASEB J"},{"issue":"4","key":"3495_CR21","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.ajpath.2011.12.027","volume":"180","author":"R Morosetti","year":"2012","unstructured":"Morosetti R, Gliubizzi C, Sancricca C, Broccolini A, Gidaro T, Lucchini M, Mirabella M (2012) TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis. Am J Pathol 180(4):1603\u20131613. https:\/\/doi.org\/10.1016\/j.ajpath.2011.12.027","journal-title":"Am J Pathol"},{"issue":"2","key":"3495_CR22","doi-asserted-by":"publisher","first-page":"e0150192","DOI":"10.1371\/journal.pone.0150192","volume":"11","author":"RS Yadava","year":"2016","unstructured":"Yadava RS, Foff EP, Yu Q, Gladman JT, Zheng TS, Mahadevan MS (2016) TWEAK regulates muscle functions in a mouse model of RNA toxicity. PLoS ONE 11(2):e0150192. https:\/\/doi.org\/10.1371\/journal.pone.0150192","journal-title":"PLoS ONE"},{"issue":"6","key":"3495_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1083\/jcb.200909117","volume":"188","author":"A Mittal","year":"2010","unstructured":"Mittal A, Bhatnagar S, Kumar A, Lach-Trifilieff E, Wauters S, Li H, Makonchuk DY, Glass DJ, Kumar A (2010) The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J Cell Biol 188(6):833\u2013849. https:\/\/doi.org\/10.1083\/jcb.200909117","journal-title":"J Cell Biol"},{"issue":"5","key":"3495_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S1074-7613(01)00232-1","volume":"15","author":"SR Wiley","year":"2001","unstructured":"Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, Liu H, Daniel TO, Smith CA, Fanslow WC (2001) A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15(5):837\u2013846. https:\/\/doi.org\/10.1016\/S1074-7613(01)00232-1","journal-title":"Immunity"},{"issue":"4","key":"3495_CR25","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1096\/fj.13-245894","volume":"28","author":"JL Chen","year":"2014","unstructured":"Chen JL, Walton KL, Winbanks CE, Murphy KT, Thomson RE, Makanji Y, Qian H, Lynch GS, Harrison CA, Gregorevic P (2014) Elevated expression of activins promotes muscle wasting and cachexia. FASEB J 28(4):1711\u20131723. https:\/\/doi.org\/10.1096\/fj.13-245894","journal-title":"FASEB J"},{"issue":"1","key":"3495_CR26","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1038\/s41467-018-06275-1","volume":"9","author":"H Winer","year":"2018","unstructured":"Winer H, Fraiberg M, Abada A, Dadosh T, Tamim-Yecheskel BC, Elazar Z (2018) Autophagy differentially regulates TNF receptor Fn14 by distinct mammalian Atg8 proteins. Nat Commun 9(1):3744. https:\/\/doi.org\/10.1038\/s41467-018-06275-1","journal-title":"Nat Commun"},{"issue":"2","key":"3495_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1158\/1078-0432.ccr-09-1929","volume":"16","author":"PA Culp","year":"2010","unstructured":"Culp PA, Choi D, Zhang Y, Yin J, Seto P, Ybarra SE, Su M, Sho M, Steinle R, Wong MHL, Evangelista F, Grove J, Cardenas M, James M, Hsi ED, Chao DT, Powers DB, Ramakrishnan V, Dubridge R (2010) Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms. Clin Cancer Res 16(2):497\u2013508. https:\/\/doi.org\/10.1158\/1078-0432.ccr-09-1929","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3495_CR28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","volume":"162","author":"AJ Johnston","year":"2015","unstructured":"Johnston AJ, Murphy KT, Jenkinson L, Laine D, Emmrich K, Faou P, Weston R, Jayatilleke KM, Schloegel J, Talbo G, Casey JL, Levina V, Wong WW, Dillon H, Sahay T, Hoogenraad J, Anderton H, Hall C, Schneider P, Tanzer M, Foley M, Scott AM, Gregorevic P, Liu SY, Burkly LC, Lynch GS, Silke J, Hoogenraad NJ (2015) Targeting of Fn14 prevents cancer-induced cachexia and prolongs survival. Cell 162(6):1365\u20131378. https:\/\/doi.org\/10.1016\/j.cell.2015.08.031","journal-title":"Cell"},{"issue":"1","key":"3495_CR29","doi-asserted-by":"publisher","first-page":"e16171","DOI":"10.1371\/journal.pone.0016171","volume":"6","author":"CL Wu","year":"2011","unstructured":"Wu CL, Kandarian SC, Jackman RW (2011) Identification of genes that elicit disuse muscle atrophy via the transcription factors p50 and Bcl-3. PLoS ONE 6(1):e16171. https:\/\/doi.org\/10.1371\/journal.pone.0016171","journal-title":"PLoS ONE"},{"issue":"7","key":"3495_CR30","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1128\/mcb.06351-11","volume":"32","author":"PK Paul","year":"2012","unstructured":"Paul PK, Bhatnagar S, Mishra V, Srivastava S, Darnay BG, Choi Y, Kumar A (2012) The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms. Mol Cell Biol 32(7):1248\u20131259. https:\/\/doi.org\/10.1128\/mcb.06351-11","journal-title":"Mol Cell Biol"},{"issue":"6","key":"3495_CR31","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1210\/jc.2009-2481","volume":"95","author":"J Vendrell","year":"2010","unstructured":"Vendrell J, Maymo-Masip E, Tinahones F, Garcia-Espana A, Megia A, Caubet E, Garcia-Fuentes E, Chacon MR (2010) Tumor necrosis-like weak inducer of apoptosis as a proinflammatory cytokine in human adipocyte cells: up-regulation in severe obesity is mediated by inflammation but not hypoxia. J Clin Endocrinol Metab 95(6):2983\u20132992. https:\/\/doi.org\/10.1210\/jc.2009-2481","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3495_CR32","doi-asserted-by":"publisher","first-page":"e65248","DOI":"10.1371\/journal.pone.0065248","volume":"8","author":"SA Brown","year":"2013","unstructured":"Brown SA, Cheng E, Williams MS, Winkles JA (2013) TWEAK-independent Fn14 self-association and NF-kappaB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain. PLoS ONE 8(6):e65248. https:\/\/doi.org\/10.1371\/journal.pone.0065248","journal-title":"PLoS ONE"},{"key":"3495_CR33","doi-asserted-by":"crossref","unstructured":"Burkly LC, Dohi T (2011) The TWEAK\/Fn14 Pathway in tissue remodeling: for better or for worse. In: Wallach D, Kovalenko A, Feldmann M (eds) Advances in TNF family research: proceedings of the 12th International TNF conference, 2009. Springer New York, New York, NY, pp 305\u2013322. doi: 10.1007\/978-1-4419-6612-4_32","DOI":"10.1007\/978-1-4419-6612-4_32"},{"issue":"14","key":"3495_CR34","doi-asserted-by":"publisher","first-page":"e13801","DOI":"10.14814\/phy2.13801","volume":"6","author":"SM Pasiakos","year":"2018","unstructured":"Pasiakos SM, Berryman CE, Carbone JW, Murphy NE, Carrigan CT, Bamman MM, Ferrando AA, Young AJ, Margolis LM (2018) Muscle Fn14 gene expression is associated with fat-free mass retention during energy deficit at high altitude. Physiol Rep 6(14):e13801. https:\/\/doi.org\/10.14814\/phy2.13801","journal-title":"Physiol Rep"},{"key":"3495_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00421-018-3943-7","author":"KE Bathgate","year":"2018","unstructured":"Bathgate KE, Bagley JR, Jo E, Talmadge RJ, Tobias IS, Brown LE, Coburn JW, Arevalo JA, Segal NL, Galpin AJ (2018) Muscle health and performance in monozygotic twins with 30 years of discordant exercise habits. Eur J Appl Physiol. https:\/\/doi.org\/10.1007\/s00421-018-3943-7","journal-title":"Eur J Appl Physiol"},{"issue":"10","key":"3495_CR36","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1152\/japplphysiol.00435.2011","volume":"112","author":"U Raue","year":"2012","unstructured":"Raue U, Trappe TA, Estrem ST, Qian H-R, Helvering LM, Smith RC, Trappe S (2012) Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults. J Appl Physiol 112(10):1625\u20131636. https:\/\/doi.org\/10.1152\/japplphysiol.00435.2011","journal-title":"J Appl Physiol"},{"issue":"5","key":"3495_CR37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1152\/japplphysiol.00759.2014","volume":"118","author":"U Raue","year":"2015","unstructured":"Raue U, Jemiolo B, Yang Y, Trappe S (2015) TWEAK-Fn14 pathway activation after exercise in human skeletal muscle: insights from two exercise modes and a time course investigation. J Appl Physiol 118(5):569\u2013578. https:\/\/doi.org\/10.1152\/japplphysiol.00759.2014","journal-title":"J Appl Physiol"},{"issue":"20","key":"3495_CR38","doi-asserted-by":"publisher","first-page":"15000","DOI":"10.1074\/jbc.M608668200","volume":"282","author":"C Dogra","year":"2007","unstructured":"Dogra C, Hall SL, Wedhas N, Linkhart TA, Kumar A (2007) Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis. J Biol Chem 282(20):15000\u201315010. https:\/\/doi.org\/10.1074\/jbc.M608668200","journal-title":"J Biol Chem"},{"issue":"1","key":"3495_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1600-065X.2011.01054.x","volume":"244","author":"LC Burkly","year":"2011","unstructured":"Burkly LC, Michaelson JS, Zheng TS (2011) TWEAK\/Fn14 pathway: an immunological switch for shaping tissue responses. Immunol Rev 244(1):99\u2013114. https:\/\/doi.org\/10.1111\/j.1600-065X.2011.01054.x","journal-title":"Immunol Rev"},{"key":"3495_CR40","unstructured":"Darras BT, Miller DT, Urion DK (1993) Dystrophinopathies. In: Pagon RA, Adam MP, Ardinger HH et al. (eds) GeneReviews(R). University of Washington, Seattle, WA, USA. All rights reserved."},{"key":"3495_CR41","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1074\/jbc.M805546200","volume":"284","author":"H Li","year":"2009","unstructured":"Li H, Mittal A, Paul P, Kumar M, Srivastava D, Tyagi S, Kumar A (2009) Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappa B-inducing kinase and p38 mitogen-activated protein kinase A potential role of MMP-9 in myopathy. J Biol Chem 284:4439\u20134450. https:\/\/doi.org\/10.1074\/jbc.M805546200","journal-title":"J Biol Chem"},{"issue":"2","key":"3495_CR42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1152\/physrev.00040.2009","volume":"90","author":"N Bakkar","year":"2010","unstructured":"Bakkar N, Guttridge DC (2010) NF-kappaB signaling: a tale of two pathways in skeletal myogenesis. Physiol Rev 90(2):495\u2013511. https:\/\/doi.org\/10.1152\/physrev.00040.2009","journal-title":"Physiol Rev"},{"issue":"23","key":"3495_CR43","doi-asserted-by":"publisher","first-page":"17432","DOI":"10.1074\/jbc.M110.131979","volume":"285","author":"SAN Brown","year":"2010","unstructured":"Brown SAN, Ghosh A, Winkles JA (2010) Full-length, membrane-anchored TWEAK can function as a juxtacrine signaling molecule and activate the NF-\u03baB pathway. J Biol Chem 285(23):17432\u201317441. https:\/\/doi.org\/10.1074\/jbc.M110.131979","journal-title":"J Biol Chem"},{"issue":"3","key":"3495_CR44","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.4049\/jimmunol.0903555","volume":"185","author":"C Roos","year":"2010","unstructured":"Roos C, Wicovsky A, Muller N, Salzmann S, Rosenthal T, Kalthoff H, Trauzold A, Seher A, Henkler F, Kneitz C, Wajant H (2010) Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway. J Immunol 185(3):1593\u20131605. https:\/\/doi.org\/10.4049\/jimmunol.0903555","journal-title":"J Immunol"},{"issue":"Pt 23","key":"3495_CR45","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1113\/jphysiol.2013.263251","volume":"591","author":"RM Murphy","year":"2013","unstructured":"Murphy RM, Lamb GD (2013) Important considerations for protein analyses using antibody based techniques: down-sizing western blotting up-sizes outcomes. J Physiol 591(Pt 23):5823\u20135831. https:\/\/doi.org\/10.1113\/jphysiol.2013.263251","journal-title":"J Physiol"},{"issue":"2","key":"3495_CR46","doi-asserted-by":"publisher","first-page":"H595","DOI":"10.1152\/ajpheart.00902.2010","volume":"300","author":"RM Murphy","year":"2011","unstructured":"Murphy RM, Mollica JP, Beard NA, Knollmann BC, Lamb GD (2011) Quantification of calsequestrin 2 (CSQ2) in sheep cardiac muscle and Ca2+-binding protein changes in CSQ2 knockout mice. Am J Physiol Heart Circ Physiol 300(2):H595\u2013604. https:\/\/doi.org\/10.1152\/ajpheart.00902.2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1\u20132","key":"3495_CR47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/B:MCBI.0000044394.66951.4d","volume":"265","author":"X Tong","year":"2004","unstructured":"Tong X, Yin L, Washington R, Rosenberg DW, Giardina C (2004) The p50\u2013p50 NF-kappaB complex as a stimulus-specific repressor of gene activation. Mol Cell Biochem 265(1\u20132):171\u2013183","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"3495_CR48","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1083\/jcb.200707179","volume":"180","author":"N Bakkar","year":"2008","unstructured":"Bakkar N, Wang J, Ladner KJ, Wang H, Dahlman JM, Carathers M, Acharyya S, Rudnicki MA, Hollenbach AD, Guttridge DC (2008) IKK\/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J Cell Biol 180(4):787\u2013802. https:\/\/doi.org\/10.1083\/jcb.200707179","journal-title":"J Cell Biol"},{"issue":"3","key":"3495_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/cvr\/cvq080","volume":"87","author":"D Alvarez-Guardia","year":"2010","unstructured":"Alvarez-Guardia D, Palomer X, Coll T, Davidson MM, Chan TO, Feldman AM, Laguna JC, Vazquez-Carrera M (2010) The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovasc Res 87(3):449\u2013458. https:\/\/doi.org\/10.1093\/cvr\/cvq080","journal-title":"Cardiovasc Res"},{"key":"3495_CR50","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2014.00018","volume":"5","author":"S Sato","year":"2014","unstructured":"Sato S, Ogura Y, Kumar A (2014) TWEAK\/Fn14 signaling axis mediates skeletal muscle atrophy and metabolic dysfunction. Front Immunol 5:18. https:\/\/doi.org\/10.3389\/fimmu.2014.00018","journal-title":"Front Immunol"},{"issue":"15","key":"3495_CR51","doi-asserted-by":"publisher","first-page":"10327","DOI":"10.1074\/jbc.M511131200","volume":"281","author":"C Dogra","year":"2006","unstructured":"Dogra C, Changotra H, Mohan S, Kumar A (2006) Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein. J Biol Chem 281(15):10327\u201310336. https:\/\/doi.org\/10.1074\/jbc.M511131200","journal-title":"J Biol Chem"},{"issue":"246","key":"3495_CR52","doi-asserted-by":"publisher","first-page":"ra75","DOI":"10.1126\/scisignal.2003086","volume":"5","author":"EK Enwere","year":"2012","unstructured":"Enwere EK, Holbrook J, Lejmi-Mrad R, Vineham J, Timusk K, Sivaraj B, Isaac M, Uehling D, Al-awar R, LaCasse E, Korneluk RG (2012) TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-kappaB signaling pathway. Sci Signal 5(246):ra75. https:\/\/doi.org\/10.1126\/scisignal.2003086","journal-title":"Sci Signal"},{"issue":"216","key":"3495_CR53","doi-asserted-by":"publisher","first-page":"ra22","DOI":"10.1126\/scisignal.2001878","volume":"5","author":"E Varfolomeev","year":"2012","unstructured":"Varfolomeev E, Goncharov T, Maecker H, Zobel K, Komuves LG, Deshayes K, Vucic D (2012) Cellular inhibitors of apoptosis are global regulators of NF-kappaB and MAPK activation by members of the TNF family of receptors. Sci Signal 5(216):ra22. https:\/\/doi.org\/10.1126\/scisignal.2001878","journal-title":"Sci Signal"},{"issue":"15","key":"3495_CR54","doi-asserted-by":"publisher","first-page":"10838","DOI":"10.1074\/jbc.275.15.10838","volume":"275","author":"WH Hu","year":"2000","unstructured":"Hu WH, Johnson H, Shu HB (2000) Activation of NF-kappaB by FADD, Casper, and caspase-8. J Biol Chem 275(15):10838\u201310844","journal-title":"J Biol Chem"},{"issue":"24","key":"3495_CR55","doi-asserted-by":"publisher","first-page":"21546","DOI":"10.1074\/jbc.M110.203745","volume":"286","author":"A Ikner","year":"2011","unstructured":"Ikner A, Ashkenazi A (2011) TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8. J Biol Chem 286(24):21546\u201321554. https:\/\/doi.org\/10.1074\/jbc.M110.203745","journal-title":"J Biol Chem"},{"issue":"1","key":"3495_CR56","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/mmbr.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75(1):50\u201383. https:\/\/doi.org\/10.1128\/mmbr.00031-10","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"3495_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/1097-4652(200101)186:1%3c104::aid-jcp1015%3e3.0.co;2-0","volume":"186","author":"NC Jones","year":"2001","unstructured":"Jones NC, Fedorov YV, Rosenthal RS, Olwin BB (2001) ERK1\/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J Cell Physiol 186(1):104\u2013115. https:\/\/doi.org\/10.1002\/1097-4652(200101)186:1%3c104:aid-jcp1015%3e3.0.co;2-0","journal-title":"J Cell Physiol"},{"issue":"10","key":"3495_CR58","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1074\/jbc.272.10.6653","volume":"272","author":"SA Coolican","year":"1997","unstructured":"Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR (1997) The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272(10):6653\u20136662","journal-title":"J Biol Chem"},{"issue":"9","key":"3495_CR59","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/s41418-018-0063-1","volume":"25","author":"S-J Xie","year":"2018","unstructured":"Xie S-J, Li J-H, Chen H-F, Tan Y-Y, Liu S-R, Zhang Y, Xu H, Yang J-H, Liu S, Zheng L-L, Huang M-B, Guo Y-H, Zhang Q, Zhou H, Qu L-H (2018) Inhibition of the JNK\/MAPK signaling pathway by myogenesis-associated miRNAs is required for skeletal muscle development. Cell Death Differ 25(9):1581\u20131597. https:\/\/doi.org\/10.1038\/s41418-018-0063-1","journal-title":"Cell Death Differ"},{"issue":"1\u20132","key":"3495_CR60","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.mce.2006.03.017","volume":"252","author":"A Keren","year":"2006","unstructured":"Keren A, Tamir Y, Bengal E (2006) The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol Cell Endocrinol 252(1\u20132):224\u2013230. https:\/\/doi.org\/10.1016\/j.mce.2006.03.017","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"3495_CR61","doi-asserted-by":"publisher","first-page":"C658","DOI":"10.1152\/ajpcell.00078.2002","volume":"284","author":"C Cabane","year":"2003","unstructured":"Cabane C, Englaro W, Yeow K, Ragno M, Derijard B (2003) Regulation of C2C12 myogenic terminal differentiation by MKK3\/p38alpha pathway. Am J Physiol Cell Physiol 284(3):C658\u2013666. https:\/\/doi.org\/10.1152\/ajpcell.00078.2002","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"3495_CR62","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/jcb.21060","volume":"100","author":"B Jin","year":"2007","unstructured":"Jin B, Li YP (2007) Curcumin prevents lipopolysaccharide-induced atrogin-1\/MAFbx upregulation and muscle mass loss. J Cell Biochem 100(4):960\u2013969. https:\/\/doi.org\/10.1002\/jcb.21060","journal-title":"J Cell Biochem"},{"issue":"11","key":"3495_CR63","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ncb1101-1014","volume":"3","author":"SC Bodine","year":"2001","unstructured":"Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD (2001) Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3(11):1014\u20131019. https:\/\/doi.org\/10.1038\/ncb1101-1014","journal-title":"Nat Cell Biol"},{"issue":"3","key":"3495_CR64","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/s1097-2765(04)00211-4","volume":"14","author":"TN Stitt","year":"2004","unstructured":"Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ (2004) The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14(3):395\u2013403. https:\/\/doi.org\/10.1016\/s1097-2765(04)00211-4","journal-title":"Mol Cell"},{"issue":"4","key":"3495_CR65","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/bph.12337","volume":"170","author":"H Wajant","year":"2013","unstructured":"Wajant H (2013) The TWEAK-Fn14 system as a potential drug target. Br J Pharmacol 170(4):748\u2013764. https:\/\/doi.org\/10.1111\/bph.12337","journal-title":"Br J Pharmacol"},{"issue":"10","key":"3495_CR66","doi-asserted-by":"publisher","first-page":"e47440","DOI":"10.1371\/journal.pone.0047440","volume":"7","author":"AB Sanz","year":"2012","unstructured":"Sanz AB, Sanchez-Ni\u00f1o MD, Carrasco S, Manzarbeitia F, Ruiz-Andres O, Selgas R, Ruiz-Ortega M, Gonzalez-Enguita C, Egido J, Ortiz A (2012) Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells. PLoS ONE 7(10):e47440\u2013e47440. https:\/\/doi.org\/10.1371\/journal.pone.0047440","journal-title":"PLoS ONE"},{"issue":"11","key":"3495_CR67","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1158\/1541-7786.mcr-09-0194","volume":"7","author":"SP Fortin","year":"2009","unstructured":"Fortin SP, Ennis MJ, Savitch BA, Carpentieri D, McDonough WS, Winkles JA, Loftus JC, Kingsley C, Hostetter G, Tran NL (2009) Tumor necrosis factor-like weak inducer of apoptosis stimulation of glioma cell survival is dependent on Akt2 function. Mol Cancer Res 7(11):1871\u20131881. https:\/\/doi.org\/10.1158\/1541-7786.mcr-09-0194","journal-title":"Mol Cancer Res"},{"issue":"5","key":"3495_CR68","doi-asserted-by":"publisher","first-page":"R146","DOI":"10.1186\/ar2038","volume":"8","author":"T Ando","year":"2006","unstructured":"Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A (2006) TWEAK\/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Arthritis Res Ther 8(5):R146. https:\/\/doi.org\/10.1186\/ar2038","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"3495_CR69","first-page":"3848","volume":"8","author":"B Yang","year":"2016","unstructured":"Yang B, Yan P, Gong H, Zuo L, Shi Y, Guo J, Guo R, Xie J, Li B (2016) TWEAK protects cardiomyocyte against apoptosis in a PI3K\/AKT pathway dependent manner. Am J Transl Res 8(9):3848\u20133860","journal-title":"Am J Transl Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03495-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-020-03495-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-020-03495-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:34:08Z","timestamp":1616286848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-020-03495-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,21]]},"references-count":69,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["3495"],"URL":"https:\/\/doi.org\/10.1007\/s00018-020-03495-x","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,21]]},"assertion":[{"value":"2 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}